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Conventional DCs constitute a rare and heterogeneous 
population of cells with unique antigen (Ag)-presenting 
functions. In mice, conventional DCs are divided into two 
subsets: CD11b-like and CD8α-like DCs. The division of 
conventional DCs into these two subsets is conserved across 
mammalian species, including human (Vu Manh et al., 
2015a,b). All CD8α-like DCs specifically express the chemo-
kine receptor XCR1. Therefore, CD8α-like DCs can be 
referred to as XCR1+ DCs.
The function of DCs in priming naive T cells for pro-
moting protective antiviral or antitumoral immunity is un-
disputable, as demonstrated by studies using mouse models 
to specifically deplete or conditionally inactivate genes in 
DCs (Bar-On and Jung, 2010a). In mice, XCR1+ DCs en-
compass CD8α+ DCs, which reside in lymphoid organs, and 
CD11b−CD103+ DCs, which reside in nonlymphoid tissues 
but migrate into draining lymph nodes to convey peripheral 
Ag to naive T cells. XCR1+ DCs excel at priming effector 
CD8+ T cells, including through uptake and processing of ex-
ogenous Ag for their presentation in association with major 
histocompatibility class (MHC) I molecules, a process called 
Ag cross-presentation (Vu Manh et al., 2015a). Upon primary 
response resolution, activated CD8+ T cells contract and give 
rise to a pool of long-lasting memory CD8+ T lymphocytes 
(mCTLs), that can swiftly and efficiently up-regulate effector 
functions upon antigen reexposure (Whitmire et al., 2008). 
Although this has been disputed (Belz et al., 2007; Mehl-
hop-Williams and Bevan, 2014), the antigen threshold nec-
essary for the activation of memory or previously stimulated 
(Ag-experienced) T cells is thought to be lower than that for 
naive T cells. Indeed, in Ag-experienced T cells, including 
mCTLs, the signaling downstream of the TCR has been re-
wired for enhanced sensitivity to Ag binding (Farber, 2009; 
Kumar et al., 2011) and lower requirement on co-stimula-
tion (Pihlgren et al., 1996; Curtsinger et al., 1998; London 
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et al., 2000; Rogers et al., 2000). Hence, contrary to naive 
T cells, Ag-experienced T cells can respond to Ag presenta-
tion by cells other than DCs, not only by other professional 
Ag-presenting cells, such as B cells or monocytes/macro-
phages, but also (and most importantly) directly by their tar-
get cells in nonlymphoid tissues, i.e., infected nonimmune 
cells or tumor cells (Croft et al., 1994; Dengler and Pober, 
2000; Macleod et al., 2014). However, the cell types, signals, 
and molecular cascades driving optimal recall effector re-
sponses of mCTLs remain ill defined. In vivo, CD11c+ cells 
help in activating mCTLs after secondary infections (Zammit 
et al., 2005). However, these cells include not only DCs but 
many other cell types (Probst et al., 2005; Bar-On and Jung, 
2010b). In vitro, isolated splenic XCR1+ DCs and CD11b+ 
DCs induce mCTL proliferation with the same efficiency 
(Mehlhop-Williams and Bevan, 2014). When comparing the 
capacity of tumor-isolated myeloid cell types to activate naive 
or Ag-experienced T cells, XCR1+ DCs are more proficient 
(Broz et al., 2014). Therefore, whether XCR1+ DCs or other 
antigen-presenting cells are necessary for optimal reactivation 
of memory T cells in vivo remains unknown.
Several mutant mouse models have been developed 
to dissect the contribution of XCR1+ DCs to immune re-
sponses in vivo. Some of these models were based on genetic 
inactivation of transcription factors critical for the ontogeny 
of XCR1+ DCs such as ID2 (inhibitor of DNA binding), 
NFIL3 (nuclear factor, IL-3 regulated), IRF8 (IFN regulatory 
factor 8), and BATF3. Mice deficient for ID2, NFIL3, and 
IRF8 are affected in the ontogeny or functions of many cell 
types besides XCR1+ DCs (Seillet and Belz, 2013). The pene-
trance of BATF3 mutation with regard to XCR1+ DC devel-
opment is incomplete on the C57BL/6J genetic background 
(Edelson et al., 2011b; Seillet et al., 2013; Mott et al., 2015). 
Other mouse models were designed to target XCR1+ DCs 
based on the expression of the human diphtheria toxin (DT) 
receptor (hDTR) under the control of the Langerin, Clec9a, 
Cd205, or Xcr1 genes. However, Langerin, Clec9a, and 
Cd205 are not specifically expressed in XCR1+ DCs (Jiang 
et al., 1995; Sancho et al., 2008; Schraml et al., 2013). Hence, 
administration of DT in Clec9a-hDTR, Langerin-hDTR, or 
Cd205-hDTR mice depletes other cell types, including other 
DC subsets (Kissenpfennig et al., 2005; Fukaya et al., 2012; 
Piva et al., 2012). The only mutant mouse model reported so 
far that specifically targets XCR1+ DCs is the Xcr1-hDTR-
venus mouse (Yamazaki et al., 2013). We present an alternative 
mutant mouse model, named Karma, which allows specific in 
vivo fluorescent tracking and ablation of XCR1+ DCs.
Here, we used Karma memory mice to transiently elim-
inate XCR1+ DCs, and investigate the involvement of these 
cells in the reactivation of mCTLs upon secondary infections 
with several pathogens. We found that XCR1+ DCs are neces-
sary for optimal expansion of mCTLs upon secondary infec-
tions with Listeria monocytogenes (Lm), Vaccinia virus (VV), 
or vesicular stomatitis virus (VSV), but not in the case of mu-
rine cytomegalovirus (MCMV). XCR1+ DCs promote recall 
of mCTLs as early as a few hours after infection with Lm, in-
dependently of the role of these cells as bacterial vehicles. Our 
results show that reactivation of mCTLs in this context relies 
on their interactions with XCR1+ DCs, a mechanism that de-
pends on IFN-γ–dependent induction of IL-12 and CXCL9 in 
XCR1+ DCs, and in part on CXCR3 engagement on mCTLs. 
In addition, NK cells are very rapidly activated upon secondary 
infection and serve as an early IFN-γ source, increasing the 
ability of XCR1+ DCs to promote the reactivation of mCTLs.
RES ULTS
Specific tracking and efficient conditional depletion  
of XCR1+ DCs in Karma mice
Comparative gene expression profiling of mouse immune 
cells identified several genes as specifically expressed by 
XCR1+ DCs, in particular the a530099j19rik gene (Fig. 1 A; 
Robbins et al., 2008; Crozat et al., 2011; Miller et al., 2012). 
We used this gene for knock-in of a construct encoding both 
the fluorescent tandem dimer Tomato (tdTomato) and the 
hDTR (Fig. 1 B) to generate a mouse model, named hereaf-
ter Karma, allowing specific tracking and conditional deple-
tion of XCR1+ DCs in vivo.
In Karma mice, all the tdTomato-positive splenocytes 
fell exclusively into the XCR1+ subset of DCs as they ex-
pressed high level of CD11c and XCR1 (Fig.  2 A). More 
than 95% of splenic XCR1+ DCs stained positive for tdTo-
mato (Fig. S1 A and Fig. 2 B). In the dermis (Fig. S1 B) and 
lungs (unpublished data), tdTomato expression was the high-
est in the XCR1+ subset of DCs (defined as CD24+CD103+ 
DCs; Fig. 2 C). In cutaneous lymph nodes (CLN; Fig. S1 C), 
tdTomato expression was the highest in both lymphoid tis-
sue-resident and dermis-derived XCR1+ DCs, and was low 
on migratory LCs (Fig. 2 D). Hence, the expression pattern of 
tdTomato in the Karma mouse model confirmed efficient tar-
geting of all migratory and lymphoid-resident XCR1+ DCs.
We next evaluated the specificity and efficiency of 
XCR1+ DC conditional depletion in Karma mice. The ad-
ministration of a single dose of DT was sufficient to eliminate 
>95% of splenic XCR1+ DCs within 6 h without affecting 
other immune cells (Fig. 2, E and F). In the spleen, the com-
partment of XCR1+ DCs was emptied for at least 2 d and 
fully recovered by day 4 after DT treatment (Fig. 2 F). DT ad-
ministration also induced an efficient elimination of XCR1+ 
DCs found in the dermis and in the CLNs (unpublished 
data). The efficiency of XCR1+ DC depletion in DT-treated 
Karma mice was functionally confirmed by two types of as-
says. First, CD11c+ cells purified from the spleens of OVA-in-
jected and DT-treated Karma mice failed to cross-present 
OVA to naive CD8+ T cells in vitro (Fig. 2 G). Second, DT-
treated Karma mice failed to produce bioactive IL-12 upon 
administration of Toxoplasma gondii–soluble tachyzoïte an-
tigen (STAg; Fig. 2 H), which specifically triggers IL-12 pro-
duction in XCR1+ DCs through TLR11 (Yarovinsky et al., 
2005). Hence, the Karma mouse model is a robust in vivo 
system that allows a selective depletion of XCR1+ DCs.
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XCR1+ DCs promote the expansion of mCTLs upon secondary 
infections with several intracellular pathogens
We used Karma mice to investigate whether XCR1+ DCs are 
required to promote the recall of mCTLs. Upon immuniza-
tion with Lm-OVA, Karma mice generated a pool of long-
lived mCTLs quantitatively and qualitatively comparable to 
those of WT mice (unpublished data). Memory DT-treated 
Karma mice were then secondary challenged with different 
OVA-expressing recombinant microbes: the bacteria model 
Lm (Lm-OVA), mouse cytomegalovirus (MCMV-OVA), VV 
(VV-OVA), or VSV (VSV-OVA). Upon secondary infection 
with Lm-OVA, VV-OVA, and VSV-OVA, a sustained deple-
tion of splenic XCR1+ DCs strongly decreased the num-
bers of Ag-specific mCTLs found in the spleen of Karma 
mice 5 d after rechallenge (Fig. 3, A and B; and Fig. S2 A). 
XCR1+ DCs also promoted the expansion of OVA-specific 
mCTLs when VSV-OVA or VV-OVA were used as immuniz-
ing agents (Fig. 3 A). Hence, the XCR1+ DC-mediated recall 
response of mCTLs is not specific to primary or secondary 
infections by Lm, but also occurs with several other infectious 
agents. Because the effect of XCR1+ DC depletion was more 
drastic for Lm-OVA than for VSV-OVA or VV-OVA second-
ary infections, we focused on Lm-OVA infection to define 
the critical time frame during which XCR1+ DCs mediate 
the reactivation of mCTLs. We therefore administered DT 
to memory Karma mice at different times around second-
ary challenge. An early and transient depletion of XCR1+ 
DCs, starting before secondary infection and lasting for ∼1.5 d 
after, significantly prevented expansion and effector functions 
of mCTLs (Fig.  3 C). In contrast, a late and sustained de-
pletion of XCR1+ DCs starting 1 d after infection had no 
effect on the recall of mCTL responses (Fig. 3 D). Because 
the intensity of the immune response to OVA-recombinant 
microbes may not reflect the immune response to Ag nat-
urally existing in the pathogen, we analyzed the activation 
of mCTLs specific of an endogenous epitope of Lm (Liste-
riolysin peptide LLO296-304) in a context of an autologous 
secondary infection (Fig. 3 E). We also examined responses 
against the nucleoprotein NP396 epitope endogenous to the 
lymphocytic choriomeningitis virus (LCMV) immunizing 
agent upon a heterologous secondary infection with VV-NP 
(unpublished data). In both cases, XCR1+ DCs promoted the 
recall of mCTLs specific to endogenous Ag (Fig. 3 E and not 
depicted). Hence, the role of XCR1+ DCs for promoting the 
recall of antigen-specific mCTLs is not limited to the OVA 
model epitope but applies to different antigens, including en-
dogenous epitopes of the immunizing or challenging infec-
tious agent. We then studied how XCR1+ DCs are required 
to promote mCTL recall within the first day after rechallenge 
using OVA as a model of Ag and OVA-expressing Lm for 
primary and secondary infections.
XCR1+ DCs promote the early activation of mCTLs upon 
secondary infection with Listeria
As early as 8 h after Lm rechallenge, mCTLs produce IFN-γ, 
in an Ag-independent fashion (Berg et al., 2003; Bajénoff et 
al., 2010; Soudja et al., 2012). We therefore analyzed whether 
depletion of XCR1+ DCs influenced this first, early phase 
of mCTL reactivation. To follow the behavior of Ag-specific 
CD8+ T cells in our experimental model, we injected low 
numbers (500–1,000) of naive GFP-expressing OT-I cells 
before each primary infection, to mimic the preimmune 
frequency of individual antigen-specific CD8+ T precur-
sors present at steady state in a mouse (Obar et al., 2008). 
Upon secondary infections, depletion of splenic XCR1+ DCs 
abrogated the early induction of IFN-γ in both OVA-spe-
cific OT-I mCTLs (Fig. 4 A and Fig. S2 B) and endogenous 
polyclonal Ag-experienced CD44hi CD8+ T cells (CD44hi 
mCTLs; Fig. 4 B and Fig. S2 B) without significantly affect-
ing their expression of Granzyme B.
Upon primary infection with Lm, XCR1+ DCs convey 
bacteria from the red pulp (RP) to the white pulp (WP) in 
the spleen, which conditions the delivery of Lm-derived Ag 
Figure 1. Expression analysis of the a530099j19rik gene and gen-
eration of Karma mice. (A) Microarray analysis of the expression of the 
a530099j19rik gene in 96 different cell types or tissues in mouse. pDCs 
(green), CD11b+ (blue), and XCR1+ (red) DCs, spleen (brown), and lymph 
nodes (yellow) are highlighted among all other cell types and tissues (gray). 
(B) Schematic representation of the Karma mouse genetic construction. 
An IRES-tdTomato-2A-DTR cassette was inserted downstream of the stop 
codon in the 3′ untranslated region of exon 2 of the a530099j19rik gene.
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Figure 2. In Karma mice, all XCR1+ DCs express the tdTomato, and are specifically and efficiently depleted upon DT administration. (A) Anal-
ysis of the tdTomato expression among total splenocytes. After dead cell exclusion, tdTomato-positive cells were analyzed for lineage (CD3ε/CD19/NK1.1), 
CD11c, SiglecH, XCR1, and CD11b expression. The percentage of cells among the gate is shown. (top) Gating strategy using control splenocytes; (bottom) 
staining of Karma splenocytes. (B–D) Analysis of tdTomato expression by DCs in spleen (B), epidermis and dermis (C), and CLNs (D) of Karma mice. See Fig. 
S1 (A–C) for details about the gating strategy used. WT cells (dotted histogram) were included in overlays to set the tdTomato background signal for com-
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to naive T cells and subsequent induction of protective CD8+ 
T cell responses (Neuenhahn et al., 2006; Aoshi et al., 2008; 
Campisi et al., 2011; Edelson et al., 2011a). Upon secondary in-
fection, Lm may also use XCR1+ DCs to disseminate into the 
spleen, which may strongly decrease antigen load in mice de-
pleted of XCR1+ DCs and thus explain their strongly dimin-
ished mCTL responses. Bacterial loads were 6.6 times lower in 
XCR1+ DC-depleted animals than in controls 6 h after infec-
tion (Fig. 4 C), confirming that XCR1+ DCs promote bacte-
rial spreading in the spleen. Yet thousands of colony-forming 
units were readily detected in the spleen of XCR1+ DC-de-
pleted mice, indicating that the amount of replicative bacteria 
was unlikely to be a limiting factor for the reactivation of 
mCTLs in the absence of XCR1+ DCs. To test this hypoth-
esis, we used CFSE-stained UV-irradiated Lm-OVA, which 
lack replicative capacity because of UV-induced DNA dam-
ages, but which retain intact structural components preserving 
their immunogenicity, unlike heat-killed bacteria (Muraille et 
al., 2005). Although similar bacterial loads were observed in 
both memory DT-treated and untreated Karma mice injected 
with UV-irradiated Lm-OVA (Fig.  4  D), the induction of 
IFN-γ in polyclonal CD44hi mCTLs was significantly lower 
in DT-treated Karma mice (Fig. 4 E). Therefore, independent 
of shuttling live bacteria, XCR1+ DCs must exert specific 
immune functions, which promote mCTL responses within 
the first hours after secondary challenges. This prompted us to 
investigate the mechanisms by which XCR1+ DCs promoted 
the reactivation of mCTLs early after secondary infection.
XCR1+ DCs promote mCTL clustering in the RP 
early after Lm infection
We first investigated whether the depletion of XCR1+ DCs 
impacted the migration of mCTLs, which occurs very early 
after secondary Lm infection (Bajénoff et al., 2010). Under 
steady-state conditions, mCTLs mostly resided in the RP of 
the spleen (Fig. 5 A, NI). Within the first hours after second-
ary infection, they transiently formed clusters around B cell 
follicles (Fig. 5 A, 6 h −DT) before migrating into the T cell 
zone (Fig. 5 A, 24 h −DT). The depletion of XCR1+ DCs 
before secondary infection significantly decreased but did not 
completely abrogate the early clustering of mCTLs (Fig. 5, 
A [6 h +DT] and B) and their later migration into the T cell 
zone (Fig. 5, A [24 h +DT] and C).
We then examined the microanatomical localization 
of XCR1+ DCs in the spleen upon secondary infection. At 
steady-state in Karma mice, XCR1+ DCs were located in 
the RP and in the T cell zone (Fig. 6 A). 6 h after rechal-
lenge, XCR1+ DCs formed clear clusters together with OT-I 
mCTLs around the marginal zone (Fig.  6  A). IFN-γ–pro-
ducing cells, which encompassed a significant proportion 
of memory OT-I cells, were strictly confined within these 
clusters (Fig.  6  B). 24  h after infection, the proportion of 
tdTomato+ cells was more prominent in the T cell zone 
as compared with the RP, suggesting that a proportion of 
XCR1+ DCs that initially resided in the RP, most proba-
bly those clustering with mCTLs at 6 h, entered the WP at 
24 h (Fig. 6 A). Altogether, these results showed that the re-
sponses of XCR1+ DCs during Lm-OVA secondary infec-
tion were tightly regulated in time and space and promoted 
mCTL clustering and IFN-γ production in the RP, at the 
edges of the marginal zone.
XCR1+ DCs secrete IL-12 and CXCL9, which respectively 
promote the activation and mobilization of mCTLs
To gain insights into the mechanisms through which XCR1+ 
DCs promoted the recall of mCTLs early after secondary in-
fection, we compared the expression of genes encoding can-
didate inflammatory cytokines and chemokines in the spleen 
of DT-treated versus untreated Karma mice after Lm rechal-
lenge. The expressions of Il12b and Cxcl9 genes were signifi-
cantly reduced in DT-treated mice as early as 3 h after infection 
(unpublished data). Upon secondary infection of memory 
mice, XCR1+ DCs were a major source of IL-12p40/70 as 
compared with CD11b+ DCs, neutrophils, and monocytes 
(Fig. 7 A and Fig. S3, A and B). The blockade of IL-12 before 
secondary inoculation with Lm-OVA drastically impaired 
IFN-γ induction in OT-I (Fig. 7 B) and polyclonal CD44hi 
(Fig. 7 C) mCTLs, suggesting that IL-12 provides the very 
first signal that initiates their reactivation. XCR1+ DCs were 
also the major producers of CXCL9 6 h after secondary chal-
lenge (Fig. 7 D and Fig. S3 C). CXCL9 staining colocalized 
strongly with clusters of XCR1+ DCs in the spleen of mem-
ory mice (Fig. 7 E). Therefore, early after secondary infection, 
XCR1+ DCs are the major source of IL-12 and CXCL9.
In C57BL/6J mice, CXCL9 and CXCL10 specifically 
bind the chemokine receptor CXCR3, which is mostly ex-
pressed on Ag-experienced effector and memory T cells (Qin 
et al., 1998; Rabin et al., 1999). Upon Lm secondary infec-
tion, CXCR3 expression was down-regulated on CD44hi 
T lymphocytes, and more profoundly on the CD8+ subset 
parison with Karma cells (black histogram). For the spleen, one experiment representative of at least four with three mice per group is shown. For the skin 
and CLNs, one representative experiment out of three with three mice per group is shown. (E and F) Specific depletion and recovery of XCR1+ DCs in Karma 
mice upon DT administration. Splenocytes of DT-injected mice were analyzed by flow cytometry 24 h (E) or several days after treatment (F). The absolute 
numbers of the analyzed cell population are represented. In these experiments, XCR1+ DCs were gated using CD8α staining in place of XCR1. Data are shown 
for one experiment representative of two independent ones, with three mice per group. (G) Antigen cross-presentation is abolished in XCR1+ DC-depleted 
mice. Data are shown for one experiment representative of two with three mice per group. Data are represented as mean ± SEM. **, P < 0.01. (H) IL-12p70 
induction is reduced in XCR1+ DC-depleted mice upon STAg administration. The experiment was performed with two noninjected (NI) control mice, and with 
three STAg-injected mice per condition. Data are represented as mean ± SEM.
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Figure 3. Splenic XCR1+ DCs promote mCTL responses upon secondary infection with various intracellular pathogens. Memory mice were used 30 
d after primary infections. (A) The DT was injected 1 d before, and 1 and 3.5 d after secondary infections with Lm-OVA, MCMV-OVA, VV-OVA, or VSV-OVA. 
Tetramer-positive cells were measured by flow cytometry 5 d after infections. See Fig. S2 for the detailed gating strategy. Graph shows pooled data (mean ± 
SEM) from two independent experiments each with two to three mice per group. *, P < 0.05; ns, not significant. NI, noninfected. (B–D) Different protocols of 
DT treatment were applied as illustrated. DT was injected 1 d before, and 1 and 3.5 d after (B), or 1 d before (C), or 1 and 3.5 d after (D) secondary infection 
with 106 CFU of Lm-OVA. Splenocytes and blood leukocytes were analyzed by flow cytometry 5 d after infection. IFN-γ, GzmB, and CCL3 induction was 
measured after in vitro restimulation with SIINFEKL. Data (mean ± SEM) are shown for one experiment representative of two with three to four mice per 
group (*, P < 0.05; ns, not significant). NI, noninfected. (E) Analysis of IFN-γ and GzmB induction in CD8+ T cells from the spleen of DT-treated memory Karma 
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than on the CD4+ one (unpublished data). CD44hi CD8+ 
T cells also migrated more efficiently than CD44hi CD4+ T 
cells in response to CXCL9 in vitro (unpublished data). We 
therefore hypothesized that the clusters of CXCL9-produc-
ing XCR1+ DCs observed in the spleen early after second-
ary infection recruited mCTLs through engagement of their 
CXCR3 receptors. In vivo blockade of CXCR3 before sec-
ondary inoculation with Lm-OVA significantly decreased the 
early production of IFN-γ by mCTLs (Fig. 7, F and G) and 
their clustering (Fig. 7 H).
Collectively, these results indicated that, within a few 
hours after secondary infection, XCR1+ DCs secreted IL-12, 
which triggered IFN-γ production by mCTLs, and CXCL9, 
which participated in the attraction of mCTLs toward 
XCR1+ DCs, and therefore in their activation.
Early IFN-γ production and NK cells promote the induction 
of CXCL9 and IL-12 in XCR1+ DCs
One of the most potent inducers of CXCL9 expression is 
IFN-γ. In vivo neutralization of IFN-γ before Lm-OVA sec-
ondary infection reduced IL-12 and abrogated CXCL9 pro-
duction by XCR1+ DCs (Fig. 8 A), resulting in a decrease 
in the clustering of mCTLs (Fig.  8  B). Therefore, IFN-γ 
constitutes one of the first signals initiating the activation of 
mCTLs upon Lm-OVA secondary infection by (a) acting in 
a positive-feedback loop on XCR1+ DCs to amplify IL-12 
induction, and (b) inducing CXCL9 expression by XCR1+ 
DCs, and the redistribution of mCTLs at the edges of mar-
ginal zones of the spleen.
Early after secondary infection, NK cells accounted for 
40% of IFN-γ–expressing splenocytes (Fig. 8 C). At that time, 
IFN-γ–producing NK cells localized into cell clusters with 
XCR1+ DCs and mCTLs around B cell follicles (Fig. 8, D 
and E, −DT). NK cell redistribution upon secondary infec-
tion depended on XCR1+ DCs, as DT treatment of Karma 
mice affected their activation and clustering (Fig. 8, D and E, 
+DT). We therefore investigated the impact of NK cell de-
pletion on the responses of XCR1+ DCs and of mCTLs. NK 
cell-depleted memory mice harbored an almost complete 
loss of IL-12 induction in XCR1+ DCs and a significant de-
crease in the expression of CXCL9 (Fig. 8 F). The induction 
of IFN-γ in mCTLs was also significantly decreased in these 
mice (Fig. 8, G and H). However, although slightly reduced, 
the number of clusters of mCTLs was not significantly al-
tered in mice depleted of NK cells (Fig. 8 I). Thus, NK cells 
contact XCR1+ DCs very rapidly during secondary infec-
tion and deliver signals that amplify the ability of XCR1+ 
DCs to reactivate mCTLs through IL-12.
Impact of the depletion of XCR1+ DCs on early mCTL 
responses during secondary challenge with VV-OVA
During secondary challenge with VV-OVA, the depletion of 
XCR1+ DCs significantly decreased the early clustering of 
mCTLs around the marginal zone (Fig.  9 A) and NK cell 
IFN-γ (Fig. 9 B), similarly to, but less strongly than, what was 
observed upon autologous secondary challenges with Lm-
OVA. Consistently with these observations, XCR1+ DCs 
were a major source of IL-12 and CXCL9 a few hours after 
secondary infection (Fig.  9 C). These data suggest that the 
recall of mCTL responses to secondary infections with Lm 
and VV are promoted by XCR1+ DCs through overlapping 
molecular and cellular mechanisms.
DIS CUSSI ON
In this study, we described a new mouse model named 
Karma, which allows specific fluorescent tracking and effi-
cient depletion of all XCR1+ DCs. The Karma mouse was 
engineered using the a530099j19Rik gene to drive the ex-
pression of the tdTomato-hDTR cassette. This gene codes 
for a predicted G protein–coupled receptor of unknown 
function. Its expression is highly specific to XCR1+ DCs 
throughout the body. Hence, the Karma mouse model is a 
good alternative to the recently described Xcr1-hDTR-ve-
nus mouse model (Yamazaki et al., 2013). We took advan-
tage of the ability to specifically and conditionally deplete 
XCR1+ DCs in the Karma mouse model to investigate the 
implication of these cells in mCTL responses to secondary 
infections by intracellular pathogens.
We established for the first time that XCR1+ DCs are 
instrumental for the expansion of mCTLs upon VV-OVA, 
VSV-OVA, and Lm-OVA secondary challenges. The use of 
the CD11c-DTR mouse model has previously shown that 
mCTL recall responses to VSV, influenza, or Lm secondary 
infections were dependent on CD11c+ cells (Zammit et al., 
2005). Here, we have identified XCR1+ DCs as the major cell 
subset involved in the reactivation of mCTLs upon VSV, VV, 
and Lm secondary infections. The amplitude of the defect pre-
viously observed in CD11c+ cell-depleted animals was more 
drastic than what we report here in XCR1+ DC-depleted in-
dividuals. This might be a result of differences in experimental 
conditions, specifically, the fact that we examined responses to 
endogenously induced mCTLs, whereas the study by Zammit 
et al. (2005) used adoptive transfer of mCTLs in naive animals 
before their challenge with autologous or heterologous patho-
gens. Alternatively, or in addition, numerous other CD11c+ 
cell subsets than XCR1+ DCs are known to be depleted in the 
CD11c-DTR model and some of these may also contribute 
to the secondary activation of mCTLs, including through pro-
duction of IL-12, IL-18, IL-15, CXCL9, or CXCL10 (Sung et 
mice 5 d after secondary challenge, after in vitro restimulation with LLO296-304 peptide. Lm-WT was used for the primary (3 × 103 CFU) and secondary (106 
CFU) infections. The protocol of DT administration applied was the same as in B. See Fig. S2 for the detailed gating strategy. Data (mean ± SEM) are shown 
for one experiment representative of two with three to four mice per group. *, P < 0.05; ns, not significant. NI, noninfected.
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al., 2012; Kastenmüller et al., 2013). During Lm-OVA second-
ary infection, XCR1+ DCs were required for the early pro-
duction of IFN-γ by mCTLs, which was previously reported 
to be independent of cognate antigen–specific interactions. 
We further deciphered the mechanisms by which XCR1+ 
DCs promote mCTL recall during secondary Lm-OVA infec-
tion. As during primary infection, the first cells in the spleen 
that host live bacteria upon Lm secondary challenge are most 
likely XCR1+ DCs. In our study, we used a high dose of 
Lm-OVA (106 CFU) for secondary challenge such that live 
bacteria could be readily detected in the spleen of XCR1+ 
DC-depleted animals. This implies that other cell types hosted 
the pathogen, such as monocytes that can be infected by Lm 
(Muraille et al., 2007; Edelson et al., 2011a). We also made use 
of UV-irradiated bacteria, which failed to actively replicate, 
to obtain the same level of infection in both XCR1+ DC-de-
pleted and control animals. The loss of XCR1+ DCs led to 
a significant reduction of mCTL recall under conditions of 
similar antigenic loads between treated and control animals. 
Altogether, our results support a mechanism whereby the acti-
vation of mCTLs during Lm secondary infection is promoted 
by their involvement in a ménage à trois with XCR1+ DCs 
and NK cells acting as an amplification loop for the activation 
of all three partners (Fig. S4).
Figure 4. XCR1+ DCs promote the early production of 
IFN-γ by mCTLs. Karma mice received 500–1000 naive GFP+ 
OT-I cells 1 d before primary infection with Lm-OVA. 30 d 
later, mice were treated with DT (open circle) or left untreated 
(black circle), and secondary infected 1 d later with 106 CFU of 
Lm-OVA. Splenocytes were harvested, incubated with brefel-
din A before intracellular staining of IFN-γ and GzmB. Fig. 
S2B contains details of the gating strategy. (A) Analysis of 
the activation of OT-I GFP+ mCTLs. ***, P < 0.001. (B) Analysis 
of IFN-γ and Granzyme B induction in all endogenous poly-
clonal mCTLs as identified by their CD44hi phenotype. Graph 
shows pooled data (mean ± SEM) from three independent 
experiments each with three mice per group. **, P < 0.01. (C) 
Bacterial load in DT-treated Karma mice after secondary in-
fection with Lm. Enumeration of Lm in spleens of DT-treated 
and untreated memory Karma mice 3, 6, and 24 h after sec-
ondary infection; L.D., limit of detection. Data are represented 
as mean ± SEM. ****, P < 0.0001. Data at 6 h are pooled from 
five independent experiments each with at least three mice 
per group. Data at 3 and 24 h are pooled from two indepen-
dent experiments each with two to three mice per group. (D 
and E) Memory DT-treated Karma mice were infected with 108 
CFU of UV-C–treated CFSE-stained Lm-OVA. Analysis of CFSE+ 
splenocytes (D) and of IFN-γ and Granzyme B induction in all 
polyclonal CD44hi mCTLs in spleens (E) of mice 6 h after sec-
ondary infection with UV-C–irradiated bacteria. Data (mean 
± SEM) are shown for one experiment representative of two 
with three to four mice per group. *, P < 0.05; ns, not signifi-
cant. NI, noninfected.
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Besides being involved in the early activation of mCTLs 
upon Lm-OVA secondary infection through IL-12 and 
CXCL9 production, XCR1+ DCs also have a critical role in 
the expansion of mCTLs, which occurs later during the recall 
response. We demonstrated that XCR1+ DCs were critical 
within the first days after infection to promote this phenom-
enon. How XCR1+ DC early functions influence the late 
expansion of mCTLs remains unknown. Several scenarios 
Figure 5. XCR1+ DCs are required for the cluster-
ing of mCTLs around the marginal zone, and promote 
their subsequent migration into the T cell zone. Mem-
ory Karma mice were generated as described in Fig. 3. (A) 
Spleen sections from untreated or DT-treated memory 
mice were stained with anti-B220 (dark blue) and anti- 
GFP (green) to define B cell follicles and OT-I mCTLs, re-
spectively, and analyzed by confocal microscopy. Bars, 200 
µm. Dotted lines delineate T cell zones. One representative 
experiment of three, each with three mice per group, is 
shown. (B) Statistical analysis of the frequency of OT-I 
mCTLs found clustered around the follicles at 6 h. Graph 
shows pooled data (mean ± SEM) from three independent 
experiments each with three mice per group. **, P < 0.01. 
(C) Statistical analysis of the frequency of OT-I mCTLs pres-
ent in the T cell zones at 24 h. Graph shows pooled data 
(mean ± SEM) from two independent experiments each 
with three mice per group. **, P < 0.01; ns, nonsignificant.
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are possible. First, XCR1+ DCs may promote mCTL expan-
sion through the secretion of soluble factors. We found that 
IL-12 and CXCL9 did not seem to be required (unpublished 
data). However, other molecules, such as the IL-15–IL-15Rα 
complex, which has strong proliferative properties on mem-
ory cells (Richer et al., 2015), may be important. Second, 
XCR1+ DCs may promote mCTL expansion through MHC 
class I–restricted Ag presentation. Third, XCR1+ DCs may 
promote mCTL expansion by recruiting the help of a third 
cell partner. Although, in our experimental setting, NK cells 
clustered with XCR1+ DCs and mCTLs, the expansion of 
mCTLs still occurred when NK cells were depleted (un-
published data). However, we cannot exclude that other cells 
may also form clusters with XCR1+ DCs and mCTLs and 
contribute to promoting the expansion of the latter. Two re-
cent studies have shown that tripartite interactions between 
XCR1+ DCs, CD4+ T cells, and primed CD8+ T cells are 
critical during primary viral infections to promote the ex-
pansion of the latter and their differentiation in protective 
mCTLs (Eickhoff et al., 2015; Hor et al., 2015). XCR1+ DCs 
physically interact with both CD4+ and CD8+ T cells, either 
sequentially when the infectious agent does not reach the 
lymphoid organs and remains confined in the peripheral tis-
sues (Hor et al., 2015), or concomitantly, forming tripartite 
clusters when the pathogen directly infects cells within the 
lymphoid tissues (Eickhoff et al., 2015). In our experimen-
tal model, upon secondary infection with Lm-OVA, CD4+ T 
cell activation was attenuated when XCR1+ DCs were absent 
(unpublished data). Therefore, as for primary infections, CD4+ 
T cells could form clusters with XCR1+ DCs and mCTLs to 
deliver a help signal necessary to promote the reactivation 
and expansion of mCTLs.
Recently, in an experimental system similar to ours, 
Soudja et al. (2012) reported that Ly6C+CCR2+ mono-
cytes were also required for this function in Lm-OVA sec-
ondary-infected animals. Combining these two studies thus 
raises the question of the respective contributions of XCR1+ 
DCs and monocytes in the promotion of mCTL responses 
upon secondary infection with Lm. To deplete monocytes, 
they used Ccr2-hDTR mice (Soudja et al., 2012). Although 
particularly high on classical monocytes, CCR2 is also ex-
pressed on cDCs, plasmacytoid DCs, nonclassical monocytes, 
activated CD4+ and CD8+ T cells, and NK cells (Mack et al., 
2001; Heng and Painter, 2008; Elpek et al., 2011; van Hel-
den et al., 2012). Indeed, DT treatment of Ccr2-hDTR mice 
eliminates not only classical monocytes but also a proportion 
of plasmacytoid DCs, XCR1+ DCs, and CD11b+ DCs (Shi 
et al., 2011; Dutertre et al., 2014). Hence, the alteration of 
mCTL responses observed in CCR2+ cell-depleted animals 
could result from the combined depletion not only of classical 
monocytes but also of other immune cells, including a frac-
tion of XCR1+ DCs. Clusters of CCR2+ cells and mCTLs are 
formed in the RP of the spleen as soon as 8 h after infection 
(Soudja et al., 2012). Interestingly, upon Lm-OVA secondary 
Figure 6. RP-associated XCR1+ DCs form clusters around the marginal zone and activate mCTLs. Memory Karma mice were generated as described 
in Fig. 3. Anti-GFP (green) and anti-dsRed (red) antibodies were used to detect memory OT-I cells and tdTomato+ XCR1+ DCs, respectively, on spleen sections 
imaged by confocal microscopy. (A) Spleen sections were stained with anti-B220 (dark blue) to define B cell follicles. (B) IFN-γ staining (pink) of spleen 
sections 6 h after secondary Lm-OVA infection. Overlay of IFN-γ staining with GFP gave a white color (arrows in insert). One representative experiment out 
of three with three mice per group is shown. Bars, 200 µm.
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Figure 7. Role of IL-12 and CXCL9 production by XCR1+ DCs in the early recruitment and activation of mCTLs after secondary infection. The 
induction of IL-12p40/70 (A) and CXCL9 (D) was analyzed by flow cytometry 6 h after Lm-OVA rechallenge in several splenocyte populations (see Fig. S3 for 
the detailed gating of cells). IL-12p40/70 and CXCL9 were not detected in any other populations than cDC subsets, neutrophils, and monocytes. Intracellular 
staining was performed directly ex vivo without prior incubation with brefeldin A. Data (mean ± SEM) are shown from one experiment representative of 
three independent ones, each with at least three mice per group. *, P < 0.05. (B and C) IL-12 neutralization abrogates IFN-γ induction in mCTLs upon second-
ary infection. Memory mice were treated with IL-12–blocking antibody (anti–IL-12) or isotype control (Isot) 18h before secondary infection. Spleens were 
harvested at 6 h after secondary Lm-OVA infection. Frequency of OT-I mCTLs (B) and of polyclonal CD44hi mCTLs (C) that produce IFN-γ 6 h post-secondary 
infection was measured as in Fig. 4. Data (mean ± SEM) are from one experiment with at least four mice per group. *, P < 0.05. (E) Spleen sections of mem-
ory Karma mice either noninfected (NI) or infected for 6 h with Lm-OVA (6 h), were stained with anti-CXCL9 (green) and anti-dsRed (red). Merged image 
shows overlay of anti-CXCL9 with anti-dsRed. Bar, 200 µm. One representative experiment of two, each with two mice per group, is shown. (F–H) Memory 
mice were treated with CXCR3-blocking antibody (anti-CXCR3) or isotype control (Isot) 18 h before secondary infection. Spleens were harvested at 6 h after 
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infection, XCR1+ DCs promote the induction of the CCR2 
ligands CCL2 and CCL7 (unpublished data). Therefore, 
XCR1+ DCs may participate in the attraction of monocytes 
in their closed vicinity, favoring cell–cell contacts and pro-
moting an optimal inflammatory milieu to mCTLs. Func-
tionally, XCR1+ DCs and classical monocytes likely mediate 
distinct and complementary functions for the reactivation of 
mCTLs. XCR1+ DCs are the main producers of CXCL9 
and IL-12, which promotes the local recruitment of mCTLs 
and their early IFN-γ production but does not affect their 
expression of the cytolytic molecule Granzyme B. Classical 
monocytes are the main producers of IL-15/IL15Rα, which 
promotes the acquisition of cytolytic functions by mCTLs 
(Soudja et al., 2012). The later expansion of mCTLs upon 
secondary infection might also depend on complementary 
functions of classical monocytes and XCR1+ DCs, for exam-
ple IL-15 transpresentation by the former and cross-presenta-
tion of Lm antigens by the later.
We showed that upon secondary challenge NK cells ac-
count for a large amount of early IFN-γ, which promoted 
IL-12 and CXCL9 production by XCR1+ DCs and their 
downstream capacity to activate mCTLs. To our knowledge, 
a role of NK cells in the promotion of the recall of mCTLs 
has never been reported. Upon primary inoculation with Lm, 
NK cells participate to a higher cytokine response 24 h after 
infection by delivering IFN-γ to XCR1+ DCs and mono-
cytes to sustain the production of IL-12 and the expression of 
inducible nitric oxide synthase, respectively (Kang et al., 2008; 
Lee et al., 2013). Interestingly, the pattern of NK cell migra-
tion during secondary infection differs in terms of time and 
localization in the spleen as compared with primary infection. 
We found that, as soon as 6 h after secondary challenge, NK 
cells, mCTLs, and XCR1+ DCs form clusters. These clus-
ters localize at the edges of the marginal zone around B cell 
follicles in the RP through which the bacteria colonizes the 
spleen. The signals triggering the recruitment of NK cells 
into these clusters are not yet known but CXCR3 engage-
ment was not necessary (unpublished data). NK cells express 
multiple chemokine receptors, including CCR2, CCR5, and 
CXCR3 (Mack et al., 2001; Bernardini et al., 2012). Hence, 
multiple chemokine receptors may exert redundant roles for 
NK cell recruitment into clusters of XCR1+ DCs upon Lm 
secondary infection. How does the attraction of NK cells by 
XCR1+ DCs influence the recall of mCTL responses? Here, 
we show that NK cells and XCR1+ DCs interact in well-or-
ganized clusters in the RP early after secondary infection by 
Lm and that this process amplifies IFN-γ and IL-12 produc-
tion by NK cells and XCR1+ DCs, respectively, promoting 
the downstream activation of mCTLs. Several reports focused 
on primary immune responses have demonstrated that the 
effectiveness of NK cell activation influences CD8+ T cell 
responses such as occurring during acute infections with 
mouse cytomegalovirus (Robbins et al., 2007; Mitrović et al., 
2012), during chronic infections with LCMV (Whitmire et 
al., 2008), or in response to tumor engraftments (Adam et al., 
2005). Altogether, these studies suggest that early interactions 
between DCs and NK cells contribute to orchestrate adaptive 
immunity against infections or tumors (Walzer et al., 2005), 
not only during acute primary immune responses but also in 
chronic infections or upon secondary challenges, by mod-
ulating the kinetic and intensity of CD4+ and CD8+ T cell 
responses depending on nature of the threat faced by the host.
CXCL9/CXCR3 signaling is implicated in the redis-
tribution of central memory T cells in interfollicular area and 
subcapsular regions in LN near pathogen entry site upon viral 
infections (Sung et al., 2012; Kastenmüller et al., 2013). In 
these studies, CXCL9 was secreted by macrophages, mono-
cytes, and CD11c+ DCs, which reside in the outermost 
areas in LN, to be presented on stromal cells, and to pro-
vide a guidance signal allowing a zone to zone relocalization 
of central memory T cells. Our study extends this concept 
to the immune response against another type of pathogen, 
an intracellular bacterium, and in another organ, the spleen, 
by demonstrating that CXCR3 signaling contributes to the 
microanatomical relocation of splenic RP mCTLs around 
CXCL9-producing XCR1+ DCs. Together with CXCL9, 
CXCL10 and CXCL11 are also high-affinity ligands for 
CXCR3. CXCL11 is not functional in C57BL/6J mice as 
a result of a single-point mutation within the coding se-
quence resulting in a frame shift (Carter et al., 2007). CXCL9 
and CXCL10 expressions, which are strongly induced in 
spleen upon Lm-OVA secondary infection, were decreased 
in XCR1+ DC-depleted mice (Fig. 7 D and not depicted). 
Therefore, CXCL9 and CXCL10 might play redundant roles 
in the attraction of mCTLs in our experimental settings. Al-
together, these results strongly suggest that the engagement of 
CXCR3 on mCTLs by CXCL9 and CXCL10 produced by 
myeloid cells upon sensing of danger signals may be a general 
and critical mechanism orchestrating in time and space the 
recall of adaptive cellular immunity against secondary infec-
tions by intracellular pathogens or against tumor resurgence.
In conclusion, by using the Karma mouse model, we 
discovered that XCR1+ DCs promote the reactivation of 
mCTLs upon Lm, VSV, and VV secondary infections. We de-
fined some of the underlying cellular and molecular mech-
anisms leading to the early activation of mCTLs upon Lm 
secondary Lm-OVA infection, cut in equal halves and processed either for flow cytometry or confocal imaging. Frequency of OT-I mCTLs (F) and of polyclonal 
CD44hi mCTLs (G) that produce IFN-γ 6 h post-secondary infection was measured as in Fig. 3. (H) Spleen sections were stained with anti-B220 (dark blue) 
and anti-GFP (green), and analyzed by confocal microscopy. Bar, 500 µm. Arrows show clusters. One representative experiment of three, each with at least 
three mice per group, is shown. Graph represents percentage of OT-I mCTLs that form clusters in anti–CXCR3-treated memory mice as mathematically 
determined. Data (mean ± SEM) are pooled from two independent experiments, each including at least three mice per group. *, P < 0.05; **, P < 0.01.
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Figure 8. The early IFN-γ production participates in the clustering of mCTLs after secondary infection. IFN-γ–blocking antibodies (anti–IFN-γ) or 
isotype control (Isot) were injected to memory mice 18 h before secondary infection. Spleens were harvested at 6 h after, cut in equal halves, and processed 
either for flow cytometry or confocal imaging. (A) Frequency of IL-12p40/70 and CXCL9-producing XCR1+ DCs in spleens. (B) Spleen sections were stained 
for GFP (green) and B220 (dark blue). Bar, 200 µm. Arrows show clusters. Graph represents percentage of OT-I mCTLs that form clusters in anti–IFN-γ-
treated memory mice as mathematically determined. Data (mean ± SEM) are shown for one experiment representative of two independent ones, each 
with at least three mice per group. *, P < 0.05; ns, nonsignificant. (C) Spleens of memory mice were harvested 6 h after secondary infection. Circle diagram 
encompasses all cells that stained positive for IFN-γ. One representative experiment out of four with three mice per group is shown. (D and E) Spleens from 
memory mice were fixed 6 h after the infection, and sections were stained with anti-GFP (green), anti-dsRed (red), and anti-NKp46 (cyan; bar, 200 µm; D), 
or with anti-GFP (green), anti–IFN-γ (red) and anti-NKp46 (cyan; bar, 50 µm; E). One representative experiment out of two, each with three mice per group, 
is shown. (F-I) Impact of NK cell depletion. (F) Frequency of IL-12p40/70 and CXCL9-producing XCR1+ DCs in spleens 6 h after Lm-OVA secondary infection. 
Data (mean ± SEM) are pooled from two independent experiments, each with at least three mice per group. *, P < 0.05; **, P < 0.01. (G and H) Frequency of 
OT-I mCTLs (G) and of polyclonal CD44hi mCTLs (H) that produce IFN-γ 6 h post-secondary infection was measured as in Fig. 3. One experiment representa-
tive of three independent ones, each with five mice per group is shown. Data are represented as mean ± SEM. *, P < 0.05. (I) Statistical analysis of clustered 
OT-I mCTLs. Data (mean ± SEM) are pooled from two independent experiments, each with at least three mice per group.
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infection. This study revealed that, besides their classical func-
tion as professional antigen cross-presenting cells critical for 
the priming of naive CD8+ T cells against many intracellu-
lar pathogens and against tumors, XCR1+ DCs are also en-
dowed with immunoregulatory functions, such as IL-12 and 
CXCL9 production, which contribute to orchestrate in time 
and space the reactivation of mCTLs.
MAT ERIALS AND MET HODS
Ethics statement regarding care and use of animals for ex-
perimentation. The animal care and use protocols (authoriza-
tion ID no. 11–09/09/2011) were designed in accordance 
with national and international laws for laboratory animal 
welfare and experimentation (EEC Council Directive 
2010/63/EU, September 2010), and approved by the Mar-
seille Ethical Committee for Animal Experimentation (regis-
tered by the Comité National de Réflexion Ethique sur 
l’Expérimentation Animale under no. 14).
Mice and in vivo treatments. The Karma mice (a530099j19rik-
tm1Ciphe) were made according to a standard gene targeting ap-
proach in C57BL/6N-derived ES cells. They were constructed 
by inserting the IRES-tdTomato-2A-hDTR cassette into the 
3′-UTR of a530099j19rik gene. Karma mice were outcrossed 
for three generations with WT C57BL/6J mice, and Karma 
littermates were used as DT-untreated controls. For neutraliz-
ing antibody experiments, WT C57BL/6J mice were pur-
chased from Charles River Laboratories. TgTcraTcrb1100Mjb; 
Rag1−/−; Rag2−/− (OT-I) mice (gift from A.-M. Schmidt-Ver-
hulst, Centre d’Immunologie de Marseille-Luminy [CIML], 
Marseille, France) were bred with C57BL/6 ubiquitinC-GFP 
mice (C57BL/6-Tg(UBC-GFP)30Scha/J; gift from Marc 
Bajénoff, CIML, Marseille, France) to obtain TgTcraTcrb1100Mjb; 
Rag2−/−; Ubc-GFP+/+ mice, from which we routinely iso-
lated GFP-expressing OT-I cells. For complete XCR1+ DC 
depletion, a dose of 32 ng/g of body weight of DT (Merck) 
was administrated at least 6 h before the experiment. For sus-
tained depletion, mice were first injected with 32 ng/g of DT, 
then received one injection of 16 ng/g every 60 h. This was 
efficient to deplete XCR1+ DCs for at least 10 d. DT was 
diluted in cold endotoxin free PBS. For in vivo antibody-de-
pendent neutralization or antibody-mediated cell depletion, 
Karma memory mice were injected i.p. with purified anti-
bodies or their corresponding isotypes (anti-NK1.1, 200 µg; 
anti-CXCR3, anti–IL-12, and anti–IFN-γ, 500 µg) 1 d before 
secondary infection. Antibodies are listed in Table S1.
Figure 9. XCR1+ DCs are the major pro-
ducers of IL-12 and CXCL9, and promote 
mCTL clustering upon secondary infection 
with VV-OVA. Karma mice received 500–
1,000 naive GFP+ OT-I cells 1 d before primary 
infection with Lm-OVA. 30 d later, mice were 
treated with DT or left untreated, and sec-
ondary infected with VV-OVA. Spleens were 
harvested 6  h after secondary challenge. (A) 
Spleen sections from untreated or DT-treated 
memory Karma mice were stained with an-
ti-B220 (dark blue) and anti-GFP (green), and 
analyzed by confocal microscopy. Bar, 200 µm. 
Statistical analysis of the frequency of OT-I 
mCTLs found clustered around the follicles. 
Graph shows data (mean ± SEM) from one rep-
resentative of two independent experiments 
each with at least three mice per group. *, P < 
0.05. (B) Analysis of IFN-γ induction in NK cells 
6 h after VV-OVA secondary challenge. Spleno-
cytes were harvested, incubated with brefeldin 
A before intracellular staining of IFN-γ. Data 
(mean ± SEM) are shown from one represen-
tative of two independent experiments, each 
with at least three mice per group. *, P < 0.05. 
(C) The induction of IL-12p40/70 and CXCL9 
was analyzed by flow cytometry in several 
splenocyte populations (see Fig. S3 for the 
detailed gating of cells). Intracellular staining 
was performed directly ex vivo without prior 
incubation with brefeldin A. Data (mean ± 
SEM) shown are pooled from two indepen-
dent experiments, each with at least three 
mice per group. **, P < 0.01; ***, P < 0.001.
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Antigen cross-presentation assay and cytokine response to 
STAg. For cross-presentation assay, Karma mice received a sin-
gle injection of DT or PBS (control) 1 d before i.v. injection 
of 2.5 mg of soluble OVA (Sigma-Aldrich). Splenic CD11c+ 
cells from Karma mice were enriched to >95% purity using 
CD11c microbeads (Miltenyi Biotec). Splenic OT-I cells 
were purified with Dynal mouse CD8 cell negative isolation 
kit (Invitrogen), and labeled with CFSE. CD11c+ and OT-I 
cells were co-cultured for 3 d at different ratio in complete 
medium supplemented with IL-2. OT-I cell proliferation rep-
resented by CFSE dilution was assessed by flow cytometry, 
and absolute numbers of OT-I cells were determined using 
Flow-Count Fluorospheres (Beckman Coulter).
For cytokine response to STAg, Karma mice received a 
single injection of DT or PBS (control) 1d before i.v. injec-
tion of 6 µg of STAg (gift from G.S. Yap, Rutgers New Jersey 
Medical School, Newark, NJ). Sera were collected 12 h after to 
detect systemic IL-12p70 induction by ELI SA (eBioscience).
Microbes. Unless stated otherwise in the figure legend, mice 
were immunized with the following OVA-expressing recom-
binant microbes: 5 × 103 colony-forming-units (CFU) of 
Listeria-OVA (Lm-OVA), 105 PFU of Vaccinia-OVA (VV-
OVA) or 2 × 104 PFU of VSV-OVA (from T. Lawrence, 
CIML, Marseille, France). Memory mice were secondary 
challenged with 106 CFU of Lm-OVA, 2 × 106 PFU of VV-
OVA or of VSV-OVA, and 3 × 104 PFU of MCMV-OVA 
(from E. Vivier, CIML, Marseille, France). Splenocytes were 
analyzed by flow cytometry 5 d later.
Lm infection and quantification of bacterial titers. The 
10403s strain, either WT Lm or Lm-OVA, was obtained from 
G. Lauvau (Albert Einstein College of Medicine, New York, 
NY). Frozen aliquots of Lm were grown in brain-heart infu-
sion (BHI) medium to a logarithmic phase (OD600 = 0.05–
0.17) and diluted in PBS before i.v. inoculation. After each 
infection, inocula were routinely plated on BHI agar plates 
to confirm their titers. For UV-C irradiation of Lm-OVA, 
fresh bacterium culture was washed twice in PBS. Suspen-
sion of 109–1010 bacteria/ml in PBS was exposed to an UVC 
lamp (254 nm; 5 J/cm2) before being stained for 10 min at 
37°C with 50 µM of CFSE. Lack of growth of UV-C–inacti-
vated Lm-OVA was confirmed by culturing 2 × 109 bacteria 
for 48 h at 37°C on BHI agar. Mice were inoculated with 
freshly prepared 108 CFU of UV-C–irradiated CFSE-stained 
Lm-OVA. To measure bacterial titers, spleens were dissociated 
on nylon mesh in 0.2% NP-40 (Igepal CA630; Sigma-Al-
drich). Serial dilutions were performed in the same buffer 
and were plated onto BHI agar plates. CFU numbers were 
counted at least 24 h later.
Spleen preparation and flow cytometry analysis. Cell suspen-
sions from spleens and CLNs were prepared and stained as 
described previously (Crozat et al., 2011). The antibodies used 
for flow cytometry are listed in the Table S1. Stained cell 
acquisition was performed on a FAC SCanto II, or on a 
LSR-II upgraded with a 561nm laser when detection of td-
Tomato expression was required.
Analysis of memory CD8+ T cell responses. 500–1,000 naive 
GFP-expressing OT-I cells were i.v. transferred in Karma 
mice 1 d before Lm primary infection. 30 d later, DT or 
neutralizing antibodies was administrated to the mice be-
fore secondary infection with Lm-OVA. When spleens and 
blood were harvested 5 d after secondary infections, cells 
were stained with H2-Kb SII NFEKL tetramers (Beckman 
Coulter) to identify OVA-specific CD8+ T cells. Splenocytes 
were also incubated for 4 h with 1 µM of SII NFEKL and 
Brefeldin A to detect intracellular IFN-γ, CCL3, and Gran-
zyme B. When spleens were harvested 6  h after secondary 
infection, splenocytes were incubated for 3 h with Brefeldin 
A in complete RPMI medium to detect spontaneous IFN-γ 
production in lymphocytes.
Immunofluorescence. Spleens were harvested, cut in 5-mm 
pieces, and fixed for at least 1 h in Antigenfix (DiaPath), then 
washed in phosphate buffer (PB1X: 0.02 M NaH2PO4 and 
0.08 M Na2HPO4) for 1 h, dehydrated in 30% sucrose over-
night at 4°C, and embedded in OCT freezing media (Sakura 
Fineteck). 16-µm frozen sections of spleens were blocked 
in PB1X containing 0.2% saponin, 2% BSA, and 2% 2.4G2 
supernatant, and stained in PB1X, 0.2% saponin. When the 
staining required, further blocking steps with normal goat 
or rabbit sera were added. Stained sections were mounted 
in ProLong Gold antifade reagent (Invitrogen), and acquired 
on a LSM780 confocal microscope (Carl Zeiss). TdTomato 
expression was amplified by using an anti-Red Fluorescent 
Protein (RFP) antibody (Rockland). Antibodies used in im-
munofluorescence are detailed in Table S1.
Quantification of memory OT-I cell clustering and migration 
into the T cell zone. OT-I cell clustering and migration into 
T cell zones were determined computationally using ImageJ 
and R graphical user interface (GUI) software. We used mo-
saic images representing a complete section of spleen to per-
form this analysis. For OT-I cell clustering: a macro program 
developed for Image J allowed us to spot individual GFP+ 
OT-I cells present on a frozen spleen section. When several 
GFP+ OT-I cells were too close to be detected as individual 
cells by the macro program due to strong signal intensity, we 
manually separated them using the pencil tool from ImageJ. 
Coordinates of each distinct GFP+ OT-I cell were retrieved. 
OT-I cell locations were then represented graphically with R 
software after installing the Fixed Point Cluster (FPC) analysis 
package. The DBS CAN algorithm was set to define a true 
cluster as a group of three or more proximate cells. Percent of 
clustered cells were then calculated according to the total 
number of cells present on the whole section. For OT-I local-
ization in the T cell zone: a macro program developed for 
Image J allowed us to enumerate all individual GFP+ OT-I 
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cells, as well as GFP+ OT-I cells found in T cell zones. As pre-
viously, merged GFP+ OT-I cells were manually separated. T 
cell regions were manually delimited according to B220 
staining of B cell follicles and nuclear density.
Microarray data. The data were downloaded from the 
BioGPS public database (http ://biogps .gnf .org; Gene 
Expression Omnibus dataset number GSE10246).
Statistical analyses. Statistical analyses were performed using 
nonparametric Mann-Whitney tests in all experiments.
Online supplemental material. Table S1 lists the antibodies 
used in this study. Fig. S1 shows the gating strategy used to 
identify DC subsets in spleen, skin, and CLNs. Fig. S2 shows 
the gating strategy used to analyze tetramer-positive mCTLs 
and the early activation of mCTLs in secondary infected 
animals. Fig. S3 shows IL-12 and CXCL9 expression analysis 
on DCs, neutrophils and monocytes from secondary infected 
animals. Fig. S4 shows a schematic model of the recall of 
mCTLs by XCR1+ DCs during secondary Lm infection. 
Online supplemental material is available at http ://www .jem 
.org /cgi /content /full /jem .20142350 /DC1.
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